DK1928235T3 - Præparat og fremgangsmåde til anvendelse i brusk-sygdoms-tilstande - Google Patents

Præparat og fremgangsmåde til anvendelse i brusk-sygdoms-tilstande

Info

Publication number
DK1928235T3
DK1928235T3 DK06813355.2T DK06813355T DK1928235T3 DK 1928235 T3 DK1928235 T3 DK 1928235T3 DK 06813355 T DK06813355 T DK 06813355T DK 1928235 T3 DK1928235 T3 DK 1928235T3
Authority
DK
Denmark
Prior art keywords
brush
diseases
preparation
brush diseases
Prior art date
Application number
DK06813355.2T
Other languages
English (en)
Inventor
Philip William Toll
Kim Gene Friesen
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Application granted granted Critical
Publication of DK1928235T3 publication Critical patent/DK1928235T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/20Inorganic substances, e.g. oligoelements
    • A23K20/30Oligoelements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
DK06813355.2T 2005-08-08 2006-08-08 Præparat og fremgangsmåde til anvendelse i brusk-sygdoms-tilstande DK1928235T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/199,350 US8377904B2 (en) 2004-02-09 2005-08-08 Composition and method for use in cartilage affecting conditions
PCT/US2006/031071 WO2007019549A2 (en) 2005-08-08 2006-08-08 Composition and method for use in cartilage affecting conditions

Publications (1)

Publication Number Publication Date
DK1928235T3 true DK1928235T3 (da) 2013-08-05

Family

ID=37728023

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06813355.2T DK1928235T3 (da) 2005-08-08 2006-08-08 Præparat og fremgangsmåde til anvendelse i brusk-sygdoms-tilstande

Country Status (12)

Country Link
US (1) US8377904B2 (da)
EP (1) EP1928235B1 (da)
JP (2) JP5739088B2 (da)
CN (2) CN104719892A (da)
AU (1) AU2006278268B2 (da)
BR (1) BRPI0614359A2 (da)
CA (1) CA2618093C (da)
DK (1) DK1928235T3 (da)
ES (1) ES2425391T3 (da)
RU (1) RU2380109C2 (da)
WO (1) WO2007019549A2 (da)
ZA (1) ZA200801644B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008103179A1 (en) * 2007-02-23 2008-08-28 Hill's Pet Nutrition, Inc. Compositions and methods for controlling the weight of animals
BRPI0812774A2 (pt) * 2007-06-06 2014-12-02 Novus Int Inc Suplementos alimentares para promoção de crescimento, reparo e manutenção de osso e juntas
IL188681A0 (en) * 2008-01-09 2008-12-29 Amino Acid Solutions Inc Pharmaceutical compositions and methods utilizing a d-amino acid
US20100316732A1 (en) * 2008-02-12 2010-12-16 Todd James Smith Beverage compositions for the promotion of joint health in companion animals
ES2480193T3 (es) * 2008-07-18 2014-07-25 Hill's Pet Nutrition, Inc. Composiciones y métodos para tratar osteoartritis
CN102884434B (zh) 2010-05-12 2015-08-19 希尔氏宠物营养品公司 用于诊断、控制和预防犬科动物炎症及减轻犬科动物炎性病况的方法
JP6029593B2 (ja) 2010-12-23 2016-11-24 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 体重減少および維持のためのペットフード組成物および方法
JP6736251B2 (ja) * 2014-10-31 2020-08-05 小林製薬株式会社 経口組成物
JP2018199728A (ja) * 2018-09-26 2018-12-20 小林製薬株式会社 経口組成物
GB201908111D0 (en) * 2019-06-06 2019-07-24 Mars Inc Modulation of the oral microbiota

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965268A (en) * 1972-04-17 1976-06-22 General Foods Corporation Expanded protein product comprising sulfur-containing organic compound
US4282254A (en) * 1979-10-04 1981-08-04 General Foods Corporation Dog food of improved acceptability
US4374135A (en) * 1980-12-05 1983-02-15 American Cyanamid Company Compositions containing anorexigenic compounds and methods for regulating the feed intake of homothermic animals
CA1302880C (en) 1986-07-25 1992-06-09 Peter Koepff Agents for the treatment of arthroses
US5053429A (en) * 1988-04-08 1991-10-01 The Lithox Corporation, Inc. Treating inflammatory pain with methionine
US5364845C1 (en) 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
US6492349B1 (en) 1993-03-31 2002-12-10 Nutramax Laboratories, Inc. Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
US5840715A (en) * 1995-12-11 1998-11-24 Inholtra Investment Holdings & Trading, N.V. Dietary regimen of nutritional supplements for relief of symptoms of arthritis
US6255295B1 (en) * 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
US5952367A (en) 1997-04-25 1999-09-14 Pak; Kyoungsik Method of treating pain cause by bursitis tendinitis arthritis
EP0891719A1 (en) 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
JPH11146771A (ja) 1997-11-17 1999-06-02 Mansho:Kk 食品用組成物及びその製造方法
US6451771B1 (en) 1999-02-12 2002-09-17 Nutramax Laboratories, Inc. Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals
ZA995557B (en) 1998-05-29 2000-04-12 Log Negentien Beleggings Pty L A chemical substance.
CA2333752A1 (en) * 1998-06-04 1999-12-09 Tarek Hammad Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
US6524609B1 (en) * 1999-08-18 2003-02-25 Nutri-Vet, Llc Treating arthritis in animals with dietary supplements
US20030224071A1 (en) 1999-08-20 2003-12-04 Howard Murad Pharmaceutical compositions and methods for managing connective tissue ailments
US6737089B2 (en) * 1999-08-27 2004-05-18 Morinda, Inc. Morinda citrifolia (Noni) enhanced animal food product
YU75003A (sh) 2002-01-11 2006-08-17 Matthias Rath Nutriciona farmaceutska formulacija koja uključuje polifenole i upotreba u tretmanu kancera
UY27260A1 (es) 2002-04-11 2003-11-28 Tredin S A Bebida alimento y sanitaria para perros
US6982254B2 (en) 2003-02-18 2006-01-03 The Procter & Gamble Company Compositions comprising a plurality of particles or agglomerates having a defined particle size
WO2005006877A1 (en) * 2003-07-03 2005-01-27 Hill's Pet Nutrition, Inc. Compositions and methods for decreasing age-related deterioration in metal activities in companion animals
US20050053673A1 (en) 2003-09-05 2005-03-10 Shrirang Netke Composition and method for facilitating bone healing
US20050176674A1 (en) 2004-02-09 2005-08-11 Friesen Kim G. Composition and method for use in cartilage affecting conditions
BRPI0519610A2 (pt) 2004-12-30 2009-02-25 Hills Pet Nutrition Inc mÉtodos para melhorar a qualidade de vida de um animal idoso ou muito idoso, de um canino de raÇa regular ou pequena, idoso ou muito idoso, de um cço de raÇa grande idoso ou muito idoso, e de um gato idoso ou muito idoso

Also Published As

Publication number Publication date
RU2008108832A (ru) 2009-09-20
CA2618093C (en) 2015-05-05
AU2006278268B2 (en) 2011-02-10
CN104719892A (zh) 2015-06-24
ES2425391T3 (es) 2013-10-15
JP2015042640A (ja) 2015-03-05
EP1928235A4 (en) 2010-03-03
RU2380109C2 (ru) 2010-01-27
JP5739088B2 (ja) 2015-06-24
US20060073192A1 (en) 2006-04-06
CN101277612A (zh) 2008-10-01
BRPI0614359A2 (pt) 2012-11-27
JP2009504662A (ja) 2009-02-05
WO2007019549A3 (en) 2007-05-31
EP1928235A2 (en) 2008-06-11
CA2618093A1 (en) 2007-02-15
WO2007019549A2 (en) 2007-02-15
ZA200801644B (en) 2009-09-30
AU2006278268A1 (en) 2007-02-15
EP1928235B1 (en) 2013-05-29
US8377904B2 (en) 2013-02-19

Similar Documents

Publication Publication Date Title
DK1928235T3 (da) Præparat og fremgangsmåde til anvendelse i brusk-sygdoms-tilstande
DK1715893T3 (da) Direkte kompressionsformulering og fremgangsmåde
IS8597A (is) Samsetningar rísedrónats og aðferðir við notkun þess
DK1937276T3 (da) Forbedret testosterongel og fremgangsmåde til anvendelse deraf
DK1924577T3 (da) Substituerede benzimidazoler og fremgangsmåder til fremstilling
DK1830926T3 (da) Oreganomundplejesammensætninger og fremgangsmåde til anvendelse heraf
IS7966A (is) Pyrazól og aðferðir við að búa þau til og notkun þeirra
DK1917246T3 (da) Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme
IS8305A (is) Bindandi smíðar og aðferðir við notkun þeirra
DK1948695T3 (da) Immunogene sammensætninger og fremgangsmåder til andvendelse
NO20081842L (no) Fremgangsmåter og sammensetninger for anvendelse ved behandling av pasienter med autoantistoff-positive sykdommer
EP1957145A4 (en) MICRONADEL ASSEMBLIES AND APPLICATION METHOD
IL184735A0 (en) Pharmaceutical formulations and methods of use
DK1969391T3 (da) Tyndfilm emitter-absorber indretning og fremgangsmåde
IL213843A0 (en) 4-aminotetracyclines and methods of use thereof
DK1760156T3 (da) Materialer og fremgangsmåder til effektiv mælkesyrefremstilling
HK1213814A1 (zh) 雙氯芬酸製劑和使用方法
EP1794589A4 (en) PROTEIN ARRAYS AND METHOD OF USE THEREOF
IS7725A (is) Imidazólópyridín og aðferðir við framleiðslu og notkun þeirra
DK2069467T3 (da) Adskillende sammensætninger og fremgangsmåder til anvendelse
DK1890570T3 (da) Tandbørstehoved og fremgangsmåde til fremstilling deraf
DK1858481T3 (da) Ophthalmologiske sammensætninger og anvendelse deraf
DK1840121T3 (da) Glycinderivat og anvendelse heraf
DK1711502T3 (da) Fremgangsmåder til at fremstille 3-O-beskyttede-morphinoner og 3-O-beskyttede morphinon-dienol-carboxylater
DK1783105T3 (da) Mørtelsammensætning, fremgangsmåde til fremstilling og anvendelse deraf